BNP Paribas Financial Markets’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.6K Sell
19,371
-39,177
-67% -$143K ﹤0.01% 4705
2026
Q1
$231K Buy
58,548
+23,475
+67% +$118K ﹤0.01% 3982
2025
Q4
$237K Sell
35,073
-7,027
-17% -$49.3K ﹤0.01% 3978
2025
Q3
$294K Sell
42,100
-11,803
-22% -$82K ﹤0.01% 3825
2025
Q2
$329K Sell
53,903
-22,539
-29% -$150K ﹤0.01% 3564
2025
Q1
$581K Buy
76,442
+29,630
+63% +$248K ﹤0.01% 3099
2024
Q4
$450K Buy
+46,812
New +$365K ﹤0.01% 3371
2019
Q1
Sell
-368,862
Closed -$660K 4358
2018
Q4
$660K Buy
368,862
+347,120
+1,597% +$1.93M ﹤0.01% 1715
2018
Q3
$134K Buy
21,742
+5,302
+32% +$24K ﹤0.01% 2592
2018
Q2
$105K Sell
16,440
-41,135
-71% -$293K ﹤0.01% 2767
2018
Q1
$401K Buy
57,575
+13,878
+32% +$162K ﹤0.01% 2357
2017
Q4
$551K Sell
43,697
-15,666
-26% -$191K ﹤0.01% 2405
2017
Q3
$705K Buy
59,363
+28,802
+94% +$427K ﹤0.01% 1789
2017
Q2
$457K Buy
30,561
+11,367
+59% +$152K ﹤0.01% 1960
2017
Q1
$183K Sell
19,194
-1,802
-9% -$15.2K ﹤0.01% 2253
2016
Q4
$186K Buy
20,996
+6,834
+48% +$61.4K ﹤0.01% 2247
2016
Q3
$122K Sell
14,162
-17,071
-55% -$135K ﹤0.01% 2005
2016
Q2
$249K Buy
31,233
+16,906
+118% +$132K ﹤0.01% 1817
2016
Q1
$125K Sell
14,327
-7,997
-36% -$66.5K ﹤0.01% 1712
2015
Q4
$209K Sell
22,324
-137
-0.6% -$1.19K ﹤0.01% 1901
2015
Q3
$217K Buy
22,461
+13,423
+149% +$142K ﹤0.01% 1899
2015
Q2
$105K Buy
9,038
+6,836
+310% +$70.3K ﹤0.01% 2059
2015
Q1
$22.9K Buy
+2,202
New +$20.6K ﹤0.01% 2309
2014
Q4
Sell
-5,517
Closed -$39.3K 2692
2014
Q3
$39.3K Buy
5,517
+5,212
+1,709% +$36.3K ﹤0.01% 2730
2014
Q2
$2.16K Buy
+305
New +$1.78K ﹤0.01% 3061
2014
Q1
Sell
-1,092
Closed -$9.54K 3637
2013
Q4
$9.54K Sell
1,092
-18,605
-94% -$114K ﹤0.01% 2675
2013
Q3
$82.1K Sell
19,697
-13,982
-42% -$77.1K ﹤0.01% 2447
2013
Q2
$238K Buy
+33,679
New +$235K ﹤0.01% 2197

Other funds holding MDXG

BNP Paribas Financial Markets's MDXG Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its MiMedx Group (MDXG) stake by 67% in Q2 2026, selling an estimated $143K and leaving 19,371 shares worth $74.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4705.

BNP Paribas Financial Markets first reported a position in MDXG in Q2 2013 and has held it in 28 quarters since. The position peaked at $705K in Q3 2017. 211 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • BNP Paribas Financial Markets held 19,371 shares of MiMedx Group worth $74.6K as of Q2 2026.
  • BNP Paribas Financial Markets sold 39,177 MiMedx Group shares in Q2 2026, an estimated $143K.
  • MiMedx Group made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4705 holding.
  • BNP Paribas Financial Markets first reported a position in MiMedx Group in Q2 2013 and has held it in 28 quarters since.
  • BNP Paribas Financial Markets's MiMedx Group position peaked at $705K in Q3 2017.
  • 211 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.